SEC 13F Intelligence

Viking Global Investors LP / EDIT

Viking Global Investors LP’s Editas Medicine Inc Position

Does Viking Global Investors LP own Editas Medicine Inc (EDIT)? Not currently — the last reported position was 413.0K shares worth $12M in Q2 2020; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$12M
Q2 2020
Shares
413.0K
% of Portfolio
+0.05%
Quarters Held
7
position exited

Position History EDIT

Reported value by quarter
Q4 ’18: $21MQ4 ’18Q1 ’19: $23MQ1 ’19Q2 ’19: $23MQ2 ’19Q3 ’19: $17MQ3 ’19Q4 ’19: $22MQ4 ’19Q1 ’20: $10MQ1 ’20Q2 ’20: $12MQ2 ’20filingsflow.com
QuarterSharesValue% of Portfolio
Q2 2020413.0K$12M+0.05%
Q1 2020512.2K$10M+0.05%
Q4 2019733.4K$22M+0.10%
Q3 2019733.4K$17M+0.09%
Q2 2019931.4K$23M+0.10%
Q1 2019931.4K$23M+0.13%
Q4 2018931.4K$21M+0.12%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Viking Global Investors LP’s full portfolio or all institutional holders of EDIT.